Key result
Kynurenic acid relaxed pre-contracted aortic rings and mesenteric arteries, and intraperitoneal injection in mice reduced blood pressure via the endothelium-dependent PI3K-Akt-eNOS pathway.
Why the study?
Several metabolites from the kynurenine pathway play a critical role in vascular function, but whether kynurenic acid relaxes blood vessels remained to be tested.
Does kynurenic acid relax blood vessels and reduce blood pressure in mice?
Does kynurenic acid relax blood vessels and reduce blood pressure in mice?
KYNA generated by KAT in perivascular brown adipocytes acts as a novel vascular relaxation factor, and its reduction may contribute to vascular dysfunction in obesity.
OBJECTIVE: Several metabolites from the kynurenine pathway of tryptophan metabolism play a critical role in vascular function and vascular wall remodeling. This study aimed to test whether metabolite kynurenic acid (KYNA) from the kynurenine pathway relaxes blood vessels. APPROACH AND RESULTS: We employed histological staining, in vitro cell culture, Western blotting, real-time PCR, and nitric oxide detection to validate kynurenine aminotransferase (KAT) localization in the vasculature as well as KYNA action on endothelial cells. We also detected vascular reactivity by organ chamber and monitored blood pressure by telemetry to investigate the regulation effect of KYNA on vascular tone. The results presented that perivascular adipose tissue (PVAT) from mice thoracic aorta had robust staining of anti-KAT1 and KYNA than PVAT from the abdominal aorta and mesenteric artery, which is consistent with the expression profile of brown adipocyte marker uncoupling protein 1. KYNA, metabolized from kynurenine by KAT, relaxed pre-contracted both aortic ring and mesenteric artery. In addition, KYNA derived from KAT in PVAT participates in the cross-talk between PVAT and vessel by mediating PVAT inhibition on agonist-induced thoracic aorta contraction. Furthermore, intraperitoneal injection of KYNA in mice reduced blood pressure. The vessel relaxation effect of KYNA was through the endothelium-dependent PI3K-Akt-eNOS pathway. Finally, the high-fat diet decreased KAT1 expression in perithoracic aortic fat and led to KYNA reduction in blood. CONCLUSIONS: Our research identified KYNA generated by KAT as a novel perivascular brown adipocyte-derived vascular relaxation factor and suggests that KYNA reduction is a critical event in vascular dysfunction under obese condition.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied Vascular tone and blood pressure. Kynurenic acid (KYNA) was evaluated on Vascular relaxation and blood pressure. Kynurenic acid relaxed pre-contracted aortic rings and mesenteric arteries, and intraperitoneal injection in mice reduced blood pressure via the endothelium-dependent PI3K-Akt-eNOS pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: